Investegate | Company Announcement

Investegate announcements from Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer

Related Keywords

Switzerland ,Japan ,United States ,France ,New York ,Germany ,American ,America ,Julie Seidel ,Genentech Roche ,Cyanamid Lederle ,Frank Weber ,Valeria Fisher ,Erich Platzer ,Ulrich Dauer ,Danne Doering ,University Cologne ,Commerzbank ,Group Strategy At Merck Kga ,Franklin Templeton ,University Of Pennsylvania ,Credit Suisse ,Company Board ,Merck Kgaa ,Lauder Institute ,Merck Co ,Bear Stearns ,Merck Kga ,Wharton School ,Zambon Group ,Trophic Communications ,Proposed Appointment ,Chief Executive ,Announces Proposed Appointment ,Chief Medical Officer ,Chief Executive Officer ,Chief Strategy ,Investor Relations Officer ,Euronext Amsterdam ,Investor Relations ,Global Clinical ,American Cyanamid ,Zambon Biotech ,Cancer Immunology ,Medical University Cologne ,Group Strategy ,Franklin European Equity Funds ,Creathor Ventures ,International Studies ,Chartered Financial Analyst ,Extraordinary General Meeting ,